352 related articles for article (PubMed ID: 9863867)
1. Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm.
Nilsson C; Mäkitalo B; Thorstensson R; Norley S; Binninger-Schinzel D; Cranage M; Rud E; Biberfeld G; Putkonen P
AIDS; 1998 Dec; 12(17):2261-70. PubMed ID: 9863867
[TBL] [Abstract][Full Text] [Related]
2. Cross-protection against mucosal simian immunodeficiency virus (SIVsm) challenge in human immunodeficiency virus type 2-vaccinated cynomolgus monkeys.
Walther-Jallow L; Nilsson C; Söderlund J; Ten Haaft P; Mäkitalo B; Biberfeld P; Böttiger P; Heeney J; Biberfeld G; Thorstensson R
J Gen Virol; 2001 Jul; 82(Pt 7):1601-1612. PubMed ID: 11413371
[TBL] [Abstract][Full Text] [Related]
3. Protection against mucosal SIVsm challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope.
Quesada-Rolander M; Mäkitalo B; Thorstensson R; Zhang YJ; Castaños-Velez E; Biberfeld G; Putkonen P
AIDS Res Hum Retroviruses; 1996 Jul; 12(11):993-9. PubMed ID: 8827215
[TBL] [Abstract][Full Text] [Related]
4. Immunization with recombinant modified vaccinia virus Ankara can modify mucosal simian immunodeficiency virus infection and delay disease progression in macaques.
Nilsson C; Sutter G; Walther-Jallow L; Ten Haaft P; Åkerblom L; Heeney J; Erfle V; Böttiger P; Biberfeld G; Thorstensson R
J Gen Virol; 2002 Apr; 83(Pt 4):807-818. PubMed ID: 11907330
[TBL] [Abstract][Full Text] [Related]
5. CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts.
Kato S; Shida H; Okamura T; Zhang X; Miura T; Mukai T; Inoue M; Shu T; Naruse TK; Kimura A; Yasutomi Y; Matsuo K
J Virol; 2021 Jan; 95(4):. PubMed ID: 33087465
[TBL] [Abstract][Full Text] [Related]
6. Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV.
Almond N; Berry N; Stebbings R; Preston M; Ham C; Page M; Ferguson D; Rose N; Li B; Mee ET; Hassall M; Stahl-Hennig C; Athanasopoulos T; Papagatsias T; Herath S; Benlahrech A; Dickson G; Meiser A; Patterson S
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413132
[TBL] [Abstract][Full Text] [Related]
7. Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virus.
Norley S; Beer B; Binninger-Schinzel D; Cosma C; Kurth R
Virology; 1996 May; 219(1):195-205. PubMed ID: 8623530
[TBL] [Abstract][Full Text] [Related]
8. Beta-chemokine production in macaques vaccinated with live attenuated virus correlates with protection against simian immunodeficiency virus (SIVsm) challenge.
Ahmed RK; Nilsson C; Wang Y; Lehner T; Biberfeld G; Thorstensson R
J Gen Virol; 1999 Jul; 80 ( Pt 7)():1569-1574. PubMed ID: 10423123
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with Live Attenuated Simian Immunodeficiency Virus (SIV) Protects from Mucosal, but Not Necessarily Intravenous, Challenge with a Minimally Heterologous SIV.
Sutton MS; Burns CM; Weiler AM; Balgeman AJ; Braasch A; Lehrer-Brey G; Friedrich TC; O'Connor SL
J Virol; 2016 Jun; 90(12):5541-5548. PubMed ID: 26962218
[TBL] [Abstract][Full Text] [Related]
10. CD8+ lymphocytes do not mediate protection against acute superinfection 20 days after vaccination with a live attenuated simian immunodeficiency virus.
Stebbings R; Berry N; Waldmann H; Bird P; Hale G; Stott J; North D; Hull R; Hall J; Lines J; Brown S; D'Arcy N; Davis L; Elsley W; Edwards C; Ferguson D; Allen J; Almond N
J Virol; 2005 Oct; 79(19):12264-72. PubMed ID: 16160152
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
[TBL] [Abstract][Full Text] [Related]
12. Resistance to superinfection by a vigorously replicating, uncloned stock of simian immunodeficiency virus (SIVmac251) stimulates replication of a live attenuated virus vaccine (SIVmacC8).
Berry N; Stebbings R; Ferguson D; Ham C; Alden J; Brown S; Jenkins A; Lines J; Duffy L; Davis L; Elsley W; Page M; Hull R; Stott J; Almond N
J Gen Virol; 2008 Sep; 89(Pt 9):2240-2251. PubMed ID: 18753233
[TBL] [Abstract][Full Text] [Related]
13. Long-term protection against SIV-induced disease in macaques vaccinated with a live attenuated HIV-2 vaccine.
Putkonen P; Walther L; Zhang YJ; Li SL; Nilsson C; Albert J; Biberfeld P; Thorstensson R; Biberfeld G
Nat Med; 1995 Sep; 1(9):914-8. PubMed ID: 7585217
[TBL] [Abstract][Full Text] [Related]
14. Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine.
Fuller DH; Rajakumar PA; Wilson LA; Trichel AM; Fuller JT; Shipley T; Wu MS; Weis K; Rinaldo CR; Haynes JR; Murphey-Corb M
J Virol; 2002 Apr; 76(7):3309-17. PubMed ID: 11884556
[TBL] [Abstract][Full Text] [Related]
15. Recombinant Herpesvirus Vectors: Durable Immune Responses and Durable Protection against Simian Immunodeficiency Virus SIVmac239 Acquisition.
Castro IM; Ricciardi MJ; Gonzalez-Nieto L; Rakasz EG; Lifson JD; Desrosiers RC; Watkins DI; Martins MA
J Virol; 2021 Jun; 95(14):e0033021. PubMed ID: 33910957
[TBL] [Abstract][Full Text] [Related]
16. Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques.
Stevceva L; Alvarez X; Lackner AA; Tryniszewska E; Kelsall B; Nacsa J; Tartaglia J; Strober W; Franchini G
J Virol; 2002 Nov; 76(22):11659-76. PubMed ID: 12388726
[TBL] [Abstract][Full Text] [Related]
17. Cell-mediated immunity to low doses of SIVsm in cynomolgus macaques did not confer protection against mucosal rechallenge.
Mäkitalo B; Böttiger1 P; Biberfeld G; Thorstensson R
Vaccine; 2000 Sep; 19(2-3):298-307. PubMed ID: 10930685
[TBL] [Abstract][Full Text] [Related]
18. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.
Almond N; Kent K; Cranage M; Rud E; Clarke B; Stott EJ
Lancet; 1995 May; 345(8961):1342-4. PubMed ID: 7752758
[TBL] [Abstract][Full Text] [Related]
19. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of nef-deleted SHIV or that having IFN-gamma against disease induced with a pathogenic virus early after vaccination.
Enose Y; Kita M; Yamamoto T; Suzuki H; Miyake A; Horiuchi R; Ibuki K; Kaneyasu K; Kuwata T; Takahashi E; Sakai K; Shinohara K; Miura T; Hayami M
Arch Virol; 2004 Sep; 149(9):1705-20. PubMed ID: 15593414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
